Brief: Poseida Therapeutics Announces Publication Highlighting Potential Of Cas-CLOVER™ As An Efficient And Robust Gene Editing System For Developing Allogeneic CAR-T Products
29/06/2022 22:53
June 29 (Reuters) - Poseida Therapeutics Inc PSTX.O :
* POSEIDA THERAPEUTICS ANNOUNCES PUBLICATION HIGHLIGHTING
POTENTIAL OF CAS-CLOVER™ AS AN EFFICIENT AND ROBUST GENE EDITING
SYSTEM FOR DEVELOPING ALLOGENEIC CAR-T PRODUCTS
Source text for Eikon: ID:nPn9tGxg3a
Further company coverage: PSTX.O
((Reuters.Briefs@thomsonreuters.com;))